Quick Takeaways
- Brian O'Callaghan has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $976.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Brian O'Callaghan
- Location
- Bedminster, NJ
- Summary
- The estimated net worth of Brian O'Callaghan is at least $976 dollars as of 16 Dec 2025. Brian O'Callaghan is the Director of Indaptus Therapeutics, Inc. and owns shares of Indaptus Therapeutics, Inc. (INDP) stock worth about $976.
- Signature
- /s/ William P. Quinn, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Brian O'Callaghan and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Indaptus Therapeutics, Inc. ($976).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Brian O'Callaghan
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| INDP | Indaptus Therapeutics, Inc. | Director | $976 | 30 Sep 2022 | ||
| BOLT | Bolt Biotherapeutics, Inc. | Director | 12 Dec 2025 | |||
| OBSV | ObsEva SA | Chief Executive Officer, Director | 01 Jan 2023 |
Insider Transactions Reported by Brian O'Callaghan:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.